UY27460A1 - Preparación de inhibidores de la proteasa de vih - Google Patents

Preparación de inhibidores de la proteasa de vih

Info

Publication number
UY27460A1
UY27460A1 UY27460A UY27460A UY27460A1 UY 27460 A1 UY27460 A1 UY 27460A1 UY 27460 A UY27460 A UY 27460A UY 27460 A UY27460 A UY 27460A UY 27460 A1 UY27460 A1 UY 27460A1
Authority
UY
Uruguay
Prior art keywords
protease inhibitors
hiv
preparation
hiv protease
formula
Prior art date
Application number
UY27460A
Other languages
English (en)
Inventor
Emmanuel Demont
Joseph Martin
Sally Redshaw
Steven Swallow
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of UY27460A1 publication Critical patent/UY27460A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)

Abstract

La presente invención se refiere a nuevos inhibidores de la proteasa del VIH de fórmula I, como isómeros individuales, racematos, mezclas no-racémicas o mezclas de diastereoisómeros, en donde A es un grupo, n, R1, R2, R3 y R4 son como se ha definido en la descripción o sales farmacéuticamente aceptables del mismos. Los compuestos de fórmula I son péptidos miméticos que actúan como inhibidores de la aspartil proteasa del VIH, una enzima esencial en el ciclo replicativo vital del VIH.
UY27460A 2001-09-28 2002-09-27 Preparación de inhibidores de la proteasa de vih UY27460A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0123467.3A GB0123467D0 (en) 2001-09-28 2001-09-28 Carbocyclic HIV Protease inhibitors

Publications (1)

Publication Number Publication Date
UY27460A1 true UY27460A1 (es) 2003-04-30

Family

ID=9922968

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27460A UY27460A1 (es) 2001-09-28 2002-09-27 Preparación de inhibidores de la proteasa de vih

Country Status (16)

Country Link
US (1) US6632826B1 (es)
EP (1) EP1432678A1 (es)
JP (1) JP2005504124A (es)
KR (1) KR20040037189A (es)
CN (1) CN1561332A (es)
BR (1) BR0213587A (es)
CA (1) CA2459868A1 (es)
GB (1) GB0123467D0 (es)
GT (1) GT200200196A (es)
MX (1) MXPA04002823A (es)
PA (1) PA8555301A1 (es)
PE (1) PE20030498A1 (es)
PL (1) PL370348A1 (es)
RU (1) RU2004113208A (es)
UY (1) UY27460A1 (es)
WO (1) WO2003029206A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101198597B (zh) * 2005-06-14 2011-11-16 先灵公司 作为天冬氨酰基蛋白酶抑制剂的化合物的制备和用途
CN104744307B (zh) * 2015-04-01 2017-01-04 新昌县大成生物科技有限公司 isostatine衍生物及其制备方法
CN104744308B (zh) * 2015-04-01 2017-01-18 新昌县大成生物科技有限公司 Iso‑ahppa衍生物及其制备方法
CN104817475B (zh) * 2015-04-01 2017-01-18 新昌县大成生物科技有限公司 Ahppa衍生物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430041A (en) 1991-05-10 1995-07-04 Hoffmann-La Roche Inc. Amino acid derivatives having antiviral activity
US5554653A (en) 1992-12-22 1996-09-10 Eli Lilly And Company Inhibitors of HIV protease useful for the treatment of AIDS
MX9308016A (es) 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
US5480887A (en) 1994-02-02 1996-01-02 Eli Lilly And Company Protease inhibitors

Also Published As

Publication number Publication date
US6632826B1 (en) 2003-10-14
EP1432678A1 (en) 2004-06-30
CN1561332A (zh) 2005-01-05
BR0213587A (pt) 2004-08-31
WO2003029206A1 (en) 2003-04-10
GB0123467D0 (en) 2001-11-21
CA2459868A1 (en) 2003-04-10
PE20030498A1 (es) 2003-06-10
JP2005504124A (ja) 2005-02-10
KR20040037189A (ko) 2004-05-04
GT200200196A (es) 2003-06-19
MXPA04002823A (es) 2004-07-05
PL370348A1 (en) 2005-05-16
RU2004113208A (ru) 2005-05-27
PA8555301A1 (es) 2003-07-28

Similar Documents

Publication Publication Date Title
MX9403380A (es) Inhibidores de proteasa de vih utiles para el tratamiento de sida.
PE20210050A1 (es) Nuevos compuestos de sulfonamida carboxamida
PE20020474A1 (es) Compuestos peptidomimeticos como inhibidores de la serina proteasa ns3 del virus de hepatitis c
ME00561B (me) Derivati sulfonamida kao pro-ljekovi inhibitora aspartil proteaze
ES2177868T3 (es) Hidroxietilaminosulfonamidas de alfa- y beta-aminoacidos utiles como inhibidores de proteasas retroviricas.
UY28423A1 (es) Inhibidores de proteasas serinas, en especial proteasa ns3-ns4a del vhc.-
DK1178958T3 (da) N-cyanomethylamider som proteaseinhibitorer
ECSP055689A (es) Inhibidor potente de la serina proteasa del vhc
UY28525A1 (es) Péptidos macrociclicos activos contra en virus de la hepatitis c
RU2007149555A (ru) Дентальная минерализация
AR042095A1 (es) Compuesto 4-oxoquinolina y aplicacion del mismo como inhibidor de integrasa de vih
UY27774A1 (es) Inhibidores de metaloproteinas de triaril-oxi-aril-espiropirimidina-2,4,6-triona
ES2157437T3 (es) Inhibidores de proteasas retrovirales de sulfonilalcanoilamino-hidroxietilamino-sulfonamida.
AR013079A1 (es) Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
ES2101252T3 (es) Inhibidores de la proteasa del hiv utiles para el tratamiento del sida.
UY27460A1 (es) Preparación de inhibidores de la proteasa de vih
UY26847A1 (es) Derivados de la pirrolidina
PE20070332A1 (es) Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasas
AR021241A1 (es) Inhibidores de proteasas
AR032622A1 (es) Compuestos de 4-amino-azepan-3-ona, composiciones farmaceuticas que los comprenden, intermediarios utiles en la sintesis de tales compuestos, procedimiento para la sintesis de dichos compuestos, y uso de tales compuestos en la fabricacion de medicamentos
UY25878A1 (es) Análogos nucleósidos antivirales
UY26846A1 (es) Derivados de la pirrolidina
BR0214104A (pt) Oligopeptìdeos e composições contendo os mesmos como inibidores de catepsina
UY26845A1 (es) Derivados de la pirimidina
UY26844A1 (es) Nuevos derivados de la pirrolidona

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141219